EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY-NC 4.0

What do patients’ efficacy and tolerability ratings of acute migraine medication tell us? Cross-sectional data from the DMKG Headache Registry

Ruth Ruscheweyh iD, Thomas Dresler, Stefanie Förderreuther, Charly Gaul, Gudrun Gossrau iD, Tim Patrick Jürgens, Victoria Ruschil, Andreas Straube, Jörg Scheidt iD

Cephalalgia · 2023-05 · 43 (5) · 033310242311748

DOI: 10.1177/03331024231174855 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Cephalalgia, online erschienen am 12.05.2023. Verfasst von Ruth Ruscheweyh und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology with Friedrich Baur Institute, LMU University Hospital, LMU Munich, Munich, Germany. Hauptthemen laut MEDLINE: Analgesics, Non-Narcotic, Migraine Disorders. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Most migraine patients need an effective acute medication. Real-world data can provide important information on the performance of acute migraine medication in clinical practice.

Methods

We used data from the German Migraine and Headache Society Headache Registry, where patients rate efficacy and tolerability of and satisfaction with each of their acute headache medications.

Results

A total of 1756 adult migraine patients (females: 85%, age: 39.5 ± 12.8 years, headache days per month: 13.5 ± 8.1) were included. Of these, 93% used acute medication, most frequently triptans (59.3%) and/or non-opioid analgesics (56.4%), and 58.5% rated efficacy as good or very good. This was more frequent for triptans (75.4%) than for non-opioid analgesics (43.6%, p < 0.001). Among non-opioid analgesics, naproxen was rated most effective (61.9% very good or good, p < 0.001 compared to ibuprofen, acetylsalicylic acid and paracetamol). Patient-rated efficacy significantly declined with higher headache frequencies (p < 0.001), and this effect remained significant after omitting patients overusing acute medication.

Conclusion

In the present population recruited at specialized headache centers, patients rated triptans as more effective than non-opioid analgesics, naproxen as more effective than ibuprofen, and acute medication efficacy decreased with increasing headache frequency.

Trial registration

The German Migraine and Headache Society Headache Registry is registered with the German Clinical Trials Register (DRKS 00021081).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Analgesics, Non-NarcoticMigraine DisordersAdultFemaleHumansMiddle AgedIbuprofenNaproxenCross-Sectional StudiesHeadacheTryptaminesRegistries

Stichwörter der Autor:innen

GermanyRegistryacute headache treatmentheadachemigrainenon-opioid analgesicspatient-reported outcome measurestriptans

Substanzen

Analgesics, Non-NarcoticIbuprofenNaproxenTryptamines

Autor:innen und Institutionen

  • Department of Neurology with Friedrich Baur Institute, LMU University Hospital, LMU Munich, Munich, Germany.
  • German Migraine and Headache Society, Frankfurt, Germany.
  • Department of Psychosomatic Medicine and Psychotherapy, Technical University of Munich, Munich, Germany.
  • LEAD Graduate School & Research Network, University of Tuebingen, Tuebingen, Germany.
  • Department of Psychiatry and Psychotherapy, Tuebingen Center for Mental Health, University Hospital of Tuebingen, Tuebingen, Germany.
  • Headache Center Frankfurt, Frankfurt, Germany.

ORCID-Profile: Ruth Ruscheweyh, Gudrun Gossrau, Jörg Scheidt

Zitieren

APA

Ruscheweyh, R., Dresler, T., Förderreuther, S., Gaul, C., Gossrau, G., Jürgens, T. P., Ruschil, V., Straube, A., & Scheidt, J. (2023). What do patients’ efficacy and tolerability ratings of acute migraine medication tell us? Cross-sectional data from the DMKG Headache Registry. Cephalalgia, 43(5), 033310242311748. https://doi.org/10.1177/03331024231174855

Vancouver

Ruscheweyh R, Dresler T, Förderreuther S, Gaul C, Gossrau G, Jürgens TP, et al. What do patients’ efficacy and tolerability ratings of acute migraine medication tell us? Cross-sectional data from the DMKG Headache Registry. Cephalalgia. 2023;43(5):033310242311748. doi:10.1177/03331024231174855

BibTeX
@article{Ruscheweyh2023,
  author = {Ruscheweyh, Ruth and Dresler, Thomas and Förderreuther, Stefanie and Gaul, Charly and Gossrau, Gudrun and Jürgens, Tim Patrick and Ruschil, Victoria and Straube, Andreas and Scheidt, Jörg},
  title = {What do patients’ efficacy and tolerability ratings of acute migraine medication tell us? Cross-sectional data from the DMKG Headache Registry},
  journal = {Cephalalgia},
  year = {2023},
  volume = {43},
  number = {5},
  pages = {033310242311748},
  doi = {10.1177/03331024231174855}
}
Kostenlos starten →